Adaptive Individualized Drug-Dose Response Modeling from a Limited Clinical Data: Case of Warfarin Management
2021 43RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE & BIOLOGY SOCIETY (EMBC)(2021)
摘要
Administration of drugs requires sophisticated methods to determine the drug quantity for optimal results, and it has been a challenging task for the number of diseases. To solve these challenges, in this paper, we present the semi-blind robust model identification technique to find individualized patient models using the minimum number of clinically acquired patient-specific data to determine optimal drug dosage. To ensure the usability of these models for dosage predictability and controller design, the model (In)validation technique is also investigated. As a case study, the patients treated with warfarin are studied to demonstrate the semi-blind robust identification and model (In)validation techniques. The performance of models is assessed by calculating minimum means squared error (MMSE).
更多查看译文
关键词
Anticoagulants,Humans,Pharmaceutical Preparations,Warfarin
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要